Cromolyn Sodium

Category
Anti-allergic
Product code
15826-37-6

Cromolyn Sodium is a mast cell stabilizer active pharmaceutical ingredient widely used for the prevention and management of allergic and inflammatory conditions. By inhibiting the release of histamine and other mediators from mast cells, Cromolyn Sodium reduces bronchoconstriction, inflammation, and allergic responses. Its local action and favorable safety profile make it suitable for long-term management of asthma and other allergic disorders. Pharmaceutical companies formulate Cromolyn Sodium into inhalation solutions, nasal sprays, and ophthalmic preparations, providing targeted delivery and effective symptom control.

Common Cromolyn Sodium Uses and Treated Conditions

  • Asthma – Helps prevent bronchospasm and reduce the frequency of asthma attacks.
  • Allergic Rhinitis – Alleviates nasal congestion, sneezing, and other allergy symptoms.
  • Conjunctivitis – Reduces ocular allergic reactions and irritation.
  • Mastocytosis and Other Allergic Disorders – Supports management of conditions involving excessive mast cell activation.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures Cromolyn Sodium API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on Cromolyn Sodium, visit the official CAS webpage.

If you’d like more information or to request a sample, contact our Generic API team today.

Cromolyn Sodium

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us